- Advertisement -

Scientists develop COVID-19 test to detect neutralizing antibodies with high sensitivity, specificity

According to a study published in Nature Biotechnology, the sVNT is capable of detecting the functional neutralizing antibodies (NAbs) that can block the binding...

New partnership aims to advance treatments for blood disorders and leukemia

A new frontier into advancing treatments for children and adults with bone marrow failure, leukemia and other blood disorders will be achieved under a...

MAIA Biotechnology Reports Third Quarter 2022 Financial Results and Provides Corporate Update – Business Wire

CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today reported financial results for...

SFU researchers help discover potential new drug to kill superbugs

Researchers in Simon Fraser University's Brinkman Laboratory are collaborating with U.S. researchers to test a new drug that can kill a wide range of...

Distinct Dendrites, Distinct Rules for Learning in a Single Neuron Mouse...

How do we learn something new? How do tasks at a new job, lyrics to the latest hit song, or directions to a friend’s...

Nerve Pathway Discovery May Lead to New Therapies for Mental Disorders

Researchers in Japan have identified a nerve pathway in mice involved in the processing of rewarding and distressing stimuli and situations. The pathway, originating in...

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s...

Thermo Fisher Scientific completed an Olink Explore HT proteomic analysis of approximately 5,500 research samples from the Michael J. Fox Foundation’s (MJFF) landmark study,...

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s Therapy

Thermo Fisher Scientific completed an Olink Explore HT proteomic analysis of approximately 5,500 research samples from the Michael J. Fox Foundation’s (MJFF) landmark study,...

In Vivo Protein Generation Using Nanoparticle Delivery: Emerging Platforms and CMC Strategies

Register Now Tao (Tony) Li, PhD Senior Director, Head of mRNA & Nanoparticle PlatformWuXi Biologics...

more new items

BMS’s New Facility, Recursion–Genentech Partnership, Long-COVID and Persistent C. auris

Bristol Myers Squibb has selected Houston as the site for a new $2.3 billion multi-modal manufacturing campus designed to support drug product and finished...

Thermo and Michael J. Fox Foundation Collaborate to Advance Proteomics-Enabled Parkinson’s...

Thermo Fisher Scientific completed an Olink Explore HT proteomic analysis of approximately 5,500 research samples from the Michael J. Fox Foundation’s (MJFF) landmark study,...

In Vivo Protein Generation Using Nanoparticle Delivery: Emerging Platforms and CMC...

Register Now Tao (Tony) Li, PhD Senior Director, Head of mRNA & Nanoparticle PlatformWuXi Biologics...